Boehringer Ingelheim News
Most Popular Boehringer Ingelheim Story
Boehringer's Pradaxa beats warfarin in major study
Boehringer Ingelheim says that its experimental blood thinner Pradaxa is safer, more effective and simpler to use than the generic warfarin, a standard therapy for treating patients with erratic Read more...
Latest Headlines
- January 10, 2012
- December 30, 2011
- September 27, 2011
- September 14, 2011
- January 11, 2011
- November 22, 2010
- November 15, 2010
- October 26, 2010
- October 20, 2010
- October 11, 2010
- October 8, 2010
- September 21, 2010
- September 20, 2010
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
